Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH

Lupus

Volumn 16, Issue 12, 2007, Pages 955-962

  Beier, F ^a   Balabanov, S ^a,b   Amberger, C C ^a   Hartmann, U ^a   Manger, K ^c   Dietz, K ^a   Kotter I ^a   Brümmendorf, Tim H ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Flow FISH; Monocyte; Systemic lupus erythematosus; Telomerase; Telomere

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TELOMERE;

ADULT; CASE-CONTROL STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MIDDLE AGED; MONOCYTES; TELOMERE;

EID: 37849021555     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307084299     Document Type: Article

References (41)

1. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-573.
2. Hayflick L. Aging under glass. Mutat Res 1991; 256: 69-80.
3. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225: 951-960.
4. Allsopp RC, Vaziri H, Patterson C et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118.
5. Brummendorf TH, Balabanov S. Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover. Leukemia 2006; 20: 1706-1716.
6. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994; 330: 1871-1879.
7. Crispin JC, cocer-Varela J. Interleukin-2 and systemic lupus erythematosus - fifteen years later. Lupus 1998; 7: 214-222.
8. Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001; 2: 764-766.
9. Rus V, Via CS. Telomeres, telomerase, and lupus: the long and short of it. Clin Immunol 2001; 99: 195-197.
10. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
11. Palucka AK, Banchereau J, Blanco P, Pascual V. The interplay of dendritic cell subsets in systemic lupus erythematosus. Immunol Cell Biol 2002; 80: 484-488.
12. Schonland SO, Lopez C, Widmann T et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 2003; 100: 13471-13476.
13. Steer SE, Williams FM, Kato B et al. Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration. Ann Rheum Dis 2007; 66: 476-480.
14. Wu K, Higashi N, Hansen ER et al. Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol 2000; 165: 4742-4747.
15. Fritsch RD, Shen X, Illei GG et al. Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2184-2197.
16. Honda M, Mengesha E, Albano S et al. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8 + CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol 2001; 99: 211-221.
17. Klapper W, Moosig F, Sotnikova A et al. Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1681-1683.
18. Kurosaka D, Yasuda J, Yoshida K et al. Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients. Lupus 2003; 12: 591-599.
19. Kurosaka D, Yasuda J, Yoshida K et al. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 1102-1107.
20. Wu CH, Hsieh SC, Li KJ, Lu MC, Yu CL. Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity. Lupus 2007; 16: 265-272.
21. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 1998; 16: 743-747.
22. Baerlocher GM, Mak J, Tien T, Lansdorp PM. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry 2002; 47: 89-99.
23. Baerlocher GM, Lansdorp PM. Telomere length measurements using fluorescence in situ hybridization and flow cytometry. Methods Cell Biol 2004; 75: 719-750.
24. Bartolovic K, Balabanov S, Berner B et al. Clonal heterogeneity in growth kinetics of CD34+. Stem Cells 2005; 23: 946-957.
25. Batliwalla FM, Damle RN, Metz C, Chiorazzi N, Gregersen PK. Simultaneous flow cytometric analysis of cell surface markers and telomere length: analysis of human tonsilar B cells. J Immunol Methods 2001; 247: 103-109.
26. Beier F, Balabanov S, Buckley T et al. Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH. Blood 2005; 106: 531-533.
27. Hartmann U, Brummendorf TH, Balabanov S et al. Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities. Haematologica 2005; 90: 307-316.
28. Rufer N, Brummendorf TH, Kolvraa S et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999; 190: 157-167.
29. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol 1992; 27: 375-382.
30. Blasco MA, Lee HW, Hande MP et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91: 25-34.
31. Knight SW, Heiss NS, Vulliamy TJ et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet 1999; 65: 50-58.
32. Vulliamy T, Marrone A, Goldman F et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001; 413: 432-435.
33. Rufer N, Brummendorf TH, Chapuis B et al. Accelerated telomere shortening in hematological lineages is limited to the first year follow-ing stem cell transplantation. Blood 2001; 97: 575-577.
34. Andrew T, Aviv A, Falchi M et al. Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am J Hum Genet 2006; 78: 480-486.
35. Slagboom PE, Droog S, Boomsma DI. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994; 55: 876-882.
36. Lansdorp PM. Stress, social rank and leukocyte telomere length. Aging Cell 2006; 5: 583-584.
37. Cherkas LF, Aviv A, Valdes AM et al. The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell 2006; 5: 361-365.
38. Valdes AM, Andrew T, Gardner JP et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-664.
39. Brummendorf TH, Holyoake TL, Rufer N et al. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 2000; 95: 1883-1890.
40. Drummond M, Lennard A, Brummendorf T, Holyoake T. Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia. Leuk Lymphoma 2004; 45: 1775-1781.
41. Fritsch RD, Shen X, Sims GP et al. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol 2005; 175: 6489-6497.